Hydroxyapatite (HA) |
Ca10 (PO4)6(OH)2
|
ERK/Sox9, BMP/Smad, Wnt, MAPK, Notch |
• Induces in vivo bone matrix mineralization, and enhances bone-implant osteointegration |
74–78
|
• Achieves superior bone quality and prevents fibrous healing of bone |
β-Tricalcium phosphate (β-TCP) |
Ca3(PO4)2
|
BMP |
• Full thickness bone ingrowth and well vascularized bone tissue |
79
|
Bisphosphonate (BP) |
(PO(OH)2) |
RANK |
• Increase bone density, which leads to a better bone integration |
80–84
|
• Improved bone mass, trabecular architecture promoted apoptosis of osteoclasts thereby reducing bone resorption |
Akermanite |
Ca2MgSi2O7
|
MAPK |
• Increased osteoblastic activity as indicated by higher osteoid secretion |
85
|
• Good osteointegration |
Bioactive glass |
45S5 Bioglass®-45% silica (SiO2), 24.5% calcium oxide (CaO), 24.5% sodium oxide (Na2O), and 6% phosphorous pentoxide (P2O5) |
MAPK |
• Robust in vivo bone in growth throughout the porous scaffold while maintaining bone-material contact without ectopic bone formation |
86 and 87
|